Genotype and risk of major bleeding during warfarin treatment.
AUTHORS
Kawai
VK ,
Cunningham
A ,
Vear
SI ,
Van Driest
SL ,
Oginni
A ,
Xu
H ,
Jiang
M ,
Li
C ,
Denny
JC ,
Shaffer
C ,
Bowton
E ,
Gage
BF ,
Ray
WA ,
Roden
DM ,
Stein
CM ,
. Pharmacogenomics. 2014 12 ; 15(16). 1973-83
- NIHMSID: 100897350
ABSTRACT
To determine whether genetic variants associated with warfarin dose variability were associated with increased risk of major bleeding during warfarin therapy.
To determine whether genetic variants associated with warfarin dose variability were associated with increased risk of major bleeding during warfarin therapy.
Tags: Faculty Publications 2014